China Biotech In Review Novartis Has A Novel Scandal Potentially Brewing

By ChinaBio Today Deals and FinancingsTianjin CanSino Biotech received a $10 million strategic investment from Lilly Asia Ventures a venture capital arm of Lilly NYSE LLY see story. CanSino special…
Read the full story: Bioportfolio Latest News